FDA: Page 76
-
FDA launches pilot to speed new ethylene oxide sterilization methods
Device makers should also reduce paper in packaging "as soon as possible" to trim the amount of the gas required for effective sterilization. The agency also named its innovation challenge winners.
By David Lim • Nov. 25, 2019 -
Retrieved from U.S. Environmental Protection Agency.
AdvaMed lobbied EPA chief Wheeler on cancer report amid delay in ethylene oxide regs
A bipartisan congressional task force is pushing EPA to issue ethylene oxide regulations that rely on EPA's 2016 report on the toxicity of the gas.
By David Lim • Nov. 22, 2019 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Medtronic's recovering DCB segment scores FDA approval of IN.PACT AV
The approval allows Medtronic to sell the paclitaxel-coated balloon as a treatment for failing arteriovenous access in dialysis patients.
By Nick Paul Taylor • Nov. 22, 2019 -
Rare medical device ban, OTC hearing aids make FDA year-end to-do list
Medical device manufacturers concerned about a federal crackdown on commercial ethylene oxide sterilizers can breathe a sigh of relief as the EPA says a timeline for final regulations remains to be determined.
By David Lim • Nov. 21, 2019 -
Transcatheter device to treat heart failure gets breakthrough designation
BioVentrix is enrolling 120 subjects in a clinical trial meant to support U.S. marketing authorization for its minimally invasive alternative to conventional surgical ventricular reconstruction.
By Nick Paul Taylor • Nov. 21, 2019 -
Trump FDA nominee Hahn advanced by Senate HELP Committee 18-5
Ranking Member Patty Murray said she would not support the nomination due to a lack of a commitment to back regulations to take non-tobacco flavored e-cigarettes that have not gone under FDA review off the market.
By David Lim • Updated Dec. 3, 2019 -
Carolina Liquid gets FDA warning over sale of unauthorized reagents
FDA said Carolina Liquid distributed Class I and II IVD reagents without regulatory clearance. The warning is the latest in a series of letters issued this year to companies for distributing devices without premarket approval.
By Nick Paul Taylor • Nov. 20, 2019 -
AdvaMed wants FDA to define 'significantly' improved for Safer Technologies Program eligibility
Although the trade association said it supports efforts to speed safer medical devices to market, it believes the agency's draft guidance lacks the specificity needed for industry to understand which devices would be eligible.
By David Lim • Nov. 19, 2019 -
FDA clears Pentax duodenoscope with disposable part in bid to cut infection risk
Center for Devices and Radiological Health Director Jeff Shuren called the clearance "another major step toward lowering the risk of infection among patients," and said duodenoscope safety is a top priority for the agency.
By David Lim • Nov. 18, 2019 -
Hospitals — and now insurers — to reveal secret rates under latest Trump admin pitch
Industry lobbies are sure to fight back against what would be a landmark shift in healthcare.
By Samantha Liss • Nov. 15, 2019 -
FDA advisers: Metal implants need beefed up ingredient labels
Industry representative Whitney Christian, a toxicologist at Medtronic, told the panel that medical device manufacturers support patients' and doctors' "right to know" what's in implants and are willing to work with FDA on the issue.
By Maria Rachal • Nov. 15, 2019 -
FDA overhauls export certificate guidance after negative feedback
AdvaMed said the draft suffered "from inaccuracies and omissions that FDA must correct." The final guidance provides more information on the appeals process and grounds for denials.
By Nick Paul Taylor • Nov. 14, 2019 -
Ewa Krawczyk, National Cancer Institute
Hologic wins FDA approval for AI-based breast imaging tech
The imaging company claims the platform saves radiologists one hour per eight hours of interpretation.
By Nick Paul Taylor • Nov. 14, 2019 -
FDA experts weigh evidence on patients' adverse reactions to common device metals
Suggestions from speakers at Wednesday's advisory panel included conducting comparative effectiveness studies, bolstering the informed consent process and requiring more stringent adverse event reporting.
By Maria Rachal • Nov. 13, 2019 -
Boston Scientific faces lower reimbursement despite White House lobbying bid
In an Office of Management and Budget meeting days before release of CMS' hospital outpatient payment final rule, execs argued the change would deter doctors from a procedure using a device that could reduce opioid dependence.
By David Lim • Nov. 13, 2019 -
Paige gets CE mark for prostate cancer detection technology
The software is designed to make it easier for pathologists to analyze biopsies for signs of cancer.
By Nick Paul Taylor • Nov. 13, 2019 -
Eudamed 2-year delay doesn't mean free pass for manufacturers
"The Eudamed project is expensive both in time and resources. It is not just an IT project, this is a change project," said Eudamed.eu CEO Richard Houlihan.
By Dana Elfin • Nov. 12, 2019 -
FDA grants breakthrough status to AI-based gastric cancer diagnostic
The technology uses artificial intelligence to analyze endoscopy images for signs of gastric cancer.
By Nick Paul Taylor • Nov. 12, 2019 -
Duodenoscope reprocessors' poor work conditions exacerbate infection problem, FDA panel says
The advisory meeting followed FDA disclosing reports of three deaths, 45 patient infections and 159 cases of device contamination related to inadequate device reprocessing between October 2018 and March 2019.
By David Lim • Nov. 8, 2019 -
Medtronic reveals high-risk cyber vulnerability in electrosurgical generators
The Department of Homeland Security rated the vulnerability, which could be exploited remotely by a low-skilled hacker, a 9.8 on a 10-point risk scale.
By Nick Paul Taylor • Nov. 8, 2019 -
Deep Dive
Ethylene oxide plant closures put US on 'cusp of a major medical logistical failure'
FDA should consider asking HHS Secretary Alex Azar to declare a public health emergency and override state legislation to get sterilization plants back online, one advisory panel member said.
By David Lim • Nov. 8, 2019 -
Medicare overpays for certain orthotic devices, OIG finds
Medicare and beneficiaries reportedly paid $341.7 million more than other payers for certain orthotic devices, building on prior investigations' findings that CMS has overpaid for services like radiation and sleep studies.
By Nick Paul Taylor • Nov. 7, 2019 -
FDA pitched progressive device pathway to Warren and Murray, reversing Gottlieb
The former FDA chief told lawmakers last year that such a framework would not be suitable for human products, but now the agency says it could speed devices for children.
By David Lim • Nov. 6, 2019 -
7 questions about ethylene oxide as FDA panel convenes
Agency advisers are meeting again Thursday, having already encouraged FDA to incentivize lower industry reliance on EtO, while acknowledging state regulators' potential to strain sterilization capacity and create device shortages.
By David Lim • Updated Nov. 7, 2019 -
As Essure implant return deadline nears, FDA study enrollment inches up
The birth control device, which Bayer stopped selling in December 2018, has been linked to nearly 33,000 reports of adverse events, including 49 deaths.
By Susan Kelly • Nov. 5, 2019
Previous
